Skip to content

Southern First Bancshares SFST Granted (in dollars per share)

Granted (in dollars per share) at other companies

Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
$1.16-39.3%
CHE
ChemedCHE
514.4-8.8%
DJT
Trump Media & Technology GroupDJT
$0.00
Southern First Bancshares logo
Southern First BancsharesSFST
$37.09+1.7%
Belden logo
BeldenBDC
$120.25+33.6%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$101.14

Other financials

Income statement

See full
Revenue$33.8M+27.6%
Net income$9.9M+87.8%
EPS (diluted)$1.19+83.1%

Balance sheet

See full
Cash & equivalents$342.8M+1,276%
Total debt$22.1M-6.3%
Total equity$379.4M+12.4%
Total assets$4.6B+6.9%

Cash flow

See full
Operating cash flow$10.8M+42.1%
CapEx$280.0K+98.6%
Free cash flow$10.5M+41.0%

Valuation

See full
Market cap$561.16M+93.1%
P/E16×+0.1×
P/S4.5×+1.5×

Profitability

See full
Net margin27.9%+9.4pp
FCF margin28.1%-9.9pp

Returns & leverage

See full
Return on equity9.8%+4.2pp
Debt / equity0.1×0.0×

Where this comes from

Reported directly by Southern First Bancshares in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: Southern First Bancshares’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Southern First Bancshares's granted (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Southern First Bancshares's granted (in dollars per share)?
Southern First Bancshares (SFST) reported granted (in dollars per share) of $37.09 in Q4 2025.
How has Southern First Bancshares's granted (in dollars per share) changed year-over-year?
Southern First Bancshares's granted (in dollars per share) increased by 1.7% year-over-year, from $36.47 to $37.09.
What does granted (in dollars per share) mean?
The weighted average grant-date fair value per share for equity awards issued during the period. This metric provides transparency into the cost basis of new equity compensation and its potential dilutive impact on existing shareholders.